Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
5-lipoxygenase-activating protein (FLAP) inhibitors
Controller for soldering iron
Display window with level of service graphical user interface
Memory circuit and method of forming the same using reduced mask steps
Systems and methods for implementing pressure sensitive keyboards
Method and an apparatus for processing an audio signal
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
  Randomly Featured Patents
Support for heat exchanger tubes
Method and apparatus for eye refraction determination
Video recording and reproducing apparatus, and control method
Directional drilling
Conveying device for machines for packaging rolls and the like
Secure device for pivotally securing a top cover on a power stapler
Means for adjusting the area of an orifice in a vibration system
Foot-operated computer input device
Bag holder
Method and apparatus to monitor/detect nodularization in ductile iron